Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy

BACKGROUND: Stromal tumor-infiltrating lymphocytes (sTILs) have been identified as a predictive biomarker for response to neoadjuvant chemotherapy (NAC) and prognosis in human epidermal growth factor receptor 2 (HER2)-positive breast cancers. However, standardized scoring methods for use in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xia, Rao, Jia, Yang, Wentao, Shui, Ruohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297199/
https://www.ncbi.nlm.nih.gov/pubmed/30406444
http://dx.doi.org/10.1007/s11523-018-0602-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297199/
https://www.ncbi.nlm.nih.gov/pubmed/30406444
http://dx.doi.org/10.1007/s11523-018-0602-1

Ejemplares similares